ArticleGynecologic oncology2012
The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin.
Hye Sook Chon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it